|
BreviblocDrug - Brevibloc The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Esmolol Hydrochloride
Strength -
20MG/ML
Applicant -
BAXTER HLTHCARE CORP
New Drug Application (NDA) Number -
019386
Product Number -
007
Therapeutic Equivalence (TE) Code -
Approval Date -
May 28, 2003
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Baxter Healthcare Corp Anesthesia Critical Care
Brevibloc
Pfizer-e Eq 500mg Base Tablet; Oral
Wyamycin S Eq 250mg Base Tablet; Oral Wyamycin S Eq 500mg Base Tablet; Oral Lexapro Eq 5mg Base/5ml Solution; Oral Lexapro 10mg Tablet; Oral Lexapro 20mg Tablet; Oral Lexapro 5mg Tablet; Oral Brevibloc 100mg/ml Injectable; Injection Brevibloc 10mg/ml Injectable; Injection Brevibloc 20mg/ml Injectable; Injection NewDrugInformation |